ID
13704
Description
A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00620321
Lien
https://clinicaltrials.gov/show/NCT00620321
Mots-clés
Versions (1)
- 29/02/2016 29/02/2016 -
Détendeur de droits
CC BY-NC 3.0
Téléchargé le
29 février 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Acute Myeloid Leukemia NCT00620321
Eligibility Acute Myeloid Leukemia NCT00620321
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
have received treatment within the last 30 days with a drug that has not received regulatory approval for any indication within 14 or 21 days of the initial dose of study drug for a non-myelosuppressive or myelosuppressive agent, respectively.
Type de données
boolean
Alias
- UMLS CUI [1]
- C1514463
Description
patients with acute promyelocytic leukemia (apml).
Type de données
boolean
Alias
- UMLS CUI [1]
- C0023487
Description
major surgery within 4 weeks of study enrollment.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0679637
Description
patients with serious pre-existing medical conditions (at the discretion of the investigator). because of the known cardiac toxicity of anthra- cyclines, patients with pre-existing ejection fraction (ef) less than or equal to 45% should not participate in this study. no patient should exceed the maximum exposure of anthracycline doses (for example, idarubicin greater than 120mg/m2).
Type de données
boolean
Alias
- UMLS CUI [1]
- C0009488
- UMLS CUI [2]
- C0232174
- UMLS CUI [3]
- C0282564
Description
patients with a second malignancy that could affect the interpretation of the results.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
patients with leukemic involvement of the cns by spinal fluid cytology or imaging.
Type de données
boolean
Alias
- UMLS CUI [1]
- C1332884
Description
patients with known coagulopathy or bleeding disorder, other than leukemia related thrombocytopenia. patients with severe of life threatening bleeding refractory to platelet transfusions are also excluded.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0005779
Description
concomitant anticoagulant therapy (with the exception of heparinized saline to maintain the patency of central venous catheters).
Type de données
boolean
Alias
- UMLS CUI [1]
- C0150457
Description
women who are pregnant or breast feeding.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
patients with a known hypersensitivity to oligonucleotides, idarubicin, and/or cytarabine.
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0028953
- UMLS CUI [1,2]
- C0020517
- UMLS CUI [2,1]
- C0020789
- UMLS CUI [2,2]
- C0020517
- UMLS CUI [3,1]
- C0010711
- UMLS CUI [3,2]
- C0020517
Similar models
Eligibility Acute Myeloid Leukemia NCT00620321
- StudyEvent: Eligibility
C0205269 (UMLS CUI [1,2])
C0277556 (UMLS CUI [1,3])
C1531552 (UMLS CUI [2])
C1444662 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C0021083 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C0279025 (UMLS CUI [4,1])
C1444662 (UMLS CUI [4,2])
C0949266 (UMLS CUI [5,1])
C1444662 (UMLS CUI [5,2])
C2004454 (UMLS CUI [6])
C0020402 (UMLS CUI [7])
C0700589 (UMLS CUI [2])
C0232174 (UMLS CUI [2])
C0282564 (UMLS CUI [3])
C0006147 (UMLS CUI [2])
C0020517 (UMLS CUI [1,2])
C0020789 (UMLS CUI [2,1])
C0020517 (UMLS CUI [2,2])
C0010711 (UMLS CUI [3,1])
C0020517 (UMLS CUI [3,2])